AstraZeneca 阿斯利康

AstraZeneca 阿斯利康
Business Name: AstraZeneca 阿斯利康
Chinese Description:

拥有百年历史的全球领先制药企业阿斯利康,自1993年进入中国,通过研发、生产、商业领域的创新,致力于满足中国人民不断增长的健康需求,造福中国患者。如今,中国已经成为阿斯利康全球第二大市场,公司在华研发投入达15亿美元,投资超过10亿美元。我们聚焦中国主要疾病领域,提供改变生命的创新药物,同时积极探索打造开放、写作、全球化的创新生态圈,汇聚全球智慧助力健康中国,更不断推进中国创新走向全球,实现我们“植根中国,服务中国,惠及全球”的长期承诺。

English Description: As a global leading pharmaceutical company with a century-year history, AstraZeneca entered China in 1993. Through innovations in R&D, operation and commerce, AstraZeneca aims to meet the increasing healthcare needs of Chinese patients and benefit Chinese patients. Today, China is AstraZeneca’s second largest market in the world. Investment into the company’s R&D in China has reached US$1.5 billion, with another investment of more than US $1 billion into manufacturing and operation sites. We focus on main disease in China and provided life changing innovative medicines. We also seek to build an open, collaborative and global healthcare innovation ecosystem, helping to bring global wisdom to help achieve the goal of “Healthy China 2030” and promoting innovations originate from China to the world, to fulfil our commitment of “in China, for China and the World”.


  • 文化无国界,人类共同体
  • CNUK
    4 Christopher Street
    London
    EC2A 2BS

    E:[email protected]
    T:+44 (0)20 3290 5588